US Stock Insider Trading | Medtronic Discloses 1 Insider Transaction on February 2

robot
Abstract generation in progress

On February 2, 2026, Medtronic (MDT) disclosed an insider trading transaction. Executive Blomquist Denise L. sold 148 shares on January 29, 2026.

【Recent Insider Transactions】

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
February 2, 2026 Executive Blomquist Denise L. January 29, 2026 Sell 148 101.00 $14,900
December 17, 2025 Director Martha Geoffrey December 15, 2025 Sell 1564 99.87 $156,200
December 17, 2025 Executive Marinaro Michael December 15, 2025 Sell 1371 99.87 $136,900
December 17, 2025 Executive Wall Brett A. December 15, 2025 Sell 439 99.87 $4,380
December 9, 2025 Executive KIIL HARRY SKIP December 5, 2025 Sell 1702 101.36 $172,500
November 21, 2025 Executive Smith Gregory L November 19, 2025 Sell 1942 101.99 $198,100
November 21, 2025 Executive Smith Gregory L November 19, 2025 Sell 24,200 101.93 $2,465,300
November 21, 2025 Executive Smith Gregory L November 19, 2025 Sell 1995 102.03 $203,500
November 21, 2025 Executive Smith Gregory L November 19, 2025 Sell 500 102.08 $5,100
November 21, 2025 Executive Smith Gregory L November 19, 2025 Sell 825 102.04 $82,400

【Company Information】

Medtronic Limited was established in 1949 and is the successor registered company of Medtronic, Inc. in Minnesota. Medtronic, Inc. was registered in Ireland as a private limited company on June 12, 2014, and re-registered as a public limited company effective January 26, 2015. The company was established to facilitate the acquisition of Covidien, a public limited company incorporated under Irish law, which was wound up on January 26, 2015 (the acquisition date). Medtronic Limited, headquartered in Dublin, Ireland, is one of the world’s largest medical technology, services, and solutions companies, serving hundreds of millions of people worldwide by alleviating pain, restoring health, and extending life. Today, it provides services to hospitals, physicians, clinicians, and patients in over 150 countries. The company’s main clients include hospitals, clinics, third-party healthcare providers, distributors, and other organizations, including government healthcare programs and group purchasing organizations (GPOs).

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)